CRISPR THERAPEUTICS AG
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $539.0M | $457.3M | $81.7M | $102.4M |
| FY2022 | $-495.7M | $-532.9M | $37.2M | $97.9M |
| FY2023 | $-260.4M | $-269.8M | $9.5M | $81.0M |
| FY2024 | $-142.8M | $-144.7M | $1.9M | $86.6M |
| FY2025 | $-345.0M | $-345.9M | $914.0K | $72.5M |